trial
as of 2026-07-01Improving Symptoms of Schizophrenia and Schizoaffective Disorder by Supplementing Medications With Pravastatin
NCTId NCT00177580
at a glance
Phase 4 · Completed
Enrollment 72 (estimated)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2007-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
72 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2003-07
Primary completion
2007-01
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of Pittsburgh Medical CenterLead Sponsor
Stanley Medical Research InstituteCollaborator
Investigators
1
Jaspreet S Brar, MD, MPHPrincipal Investigator
Sites
1 total
Pittsburgh, United States
Facts & assertions
4 sourced
Enrollment
72
Phase
PHASE4
Primary Completion Date
2007-01
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
investigator
person